Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NorTick_EM: Antibiotics for Erythema Migrans
NCT01368341Phase 4Completed
- Start
- Jun 2011
- Primary completion
- Dec 2013
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of phenoxymethylpenicillin, amoxicillin, doxycycline in erythema migrans (EM). Started Jun 2011; status: completed.
02
Drugs
phenoxymethylpenicillinamoxicillindoxycycline
03
Conditions
erythema migrans (EM)
Beyond the preview
Go deeper on NCT01368341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01368341.